+Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life

<p>Abstract</p> <p>Background</p> <p>The MacDQoL is an individualised measure of the impact of macular degeneration (MD) on quality of life (QoL). There is preliminary evidence of its psychometric properties and sensitivity to severity of MD. The aim of this study was t...

Full description

Bibliographic Details
Main Authors: ffytche Timothy, McMillan Carolyn V, Anderson Stephen J, Woodcock Alison, Wolffsohn James S, Mitchell Jan, Rubinstein Martin, Amoaku Winfried, Bradley Clare
Format: Article
Language:English
Published: BMC 2005-04-01
Series:Health and Quality of Life Outcomes
Online Access:http://www.hqlo.com/content/3/1/25
_version_ 1811315076565565440
author ffytche Timothy
McMillan Carolyn V
Anderson Stephen J
Woodcock Alison
Wolffsohn James S
Mitchell Jan
Rubinstein Martin
Amoaku Winfried
Bradley Clare
author_facet ffytche Timothy
McMillan Carolyn V
Anderson Stephen J
Woodcock Alison
Wolffsohn James S
Mitchell Jan
Rubinstein Martin
Amoaku Winfried
Bradley Clare
author_sort ffytche Timothy
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The MacDQoL is an individualised measure of the impact of macular degeneration (MD) on quality of life (QoL). There is preliminary evidence of its psychometric properties and sensitivity to severity of MD. The aim of this study was to carry out further psychometric evaluation with a larger sample and investigate the measure's sensitivity to MD severity.</p> <p>Methods</p> <p>Patients with MD (n = 156: 99 women, 57 men, mean age 79 ± 13 years), recruited from eye clinics (one NHS, one private) completed the MacDQoL by telephone interview and later underwent a clinic vision assessment including near and distance visual acuity (VA), comfortable near VA, contrast sensitivity, colour recognition, recovery from glare and presence or absence of distortion or scotoma in the central 10° of the visual field.</p> <p>Results</p> <p>The completion rate for the MacDQoL items was 99.8%. Of the 26 items, three were dropped from the measure due to redundancy. A fourth was retained in the questionnaire but excluded when computing the scale score. Principal components analysis and Cronbach's alpha (0.944) supported combining the remaining 22 items in a single scale. Lower MacDQoL scores, indicating more negative impact of MD on QoL, were associated with poorer distance VA (better eye r = -0.431 p < 0.001; worse eye r = -0.350 p < 0.001; binocular vision r = -0.419 p < 0.001) and near VA (better eye r = -0.326 p < 0.001; worse eye r = -0.226 p < 0.001; binocular vision r = -0.326 p < 0.001). Poorer MacDQoL scores were associated with poorer contrast sensitivity (better eye r = 0.392 p < 0.001; binocular vision r = 0.423 p < 0.001), poorer colour recognition (r = 0.417 p < 0.001) and poorer comfortable near VA (r = -0.283, p < 0.001). The MacDQoL differentiated between those with and without binocular scotoma (U = 1244 p < 0.001).</p> <p>Conclusion</p> <p>The MacDQoL 22-item scale has excellent internal consistency reliability and a single-factor structure. The measure is acceptable to respondents and the generic QoL item, MD-specific QoL item and average weighted impact score are related to several measures of vision. The MacDQoL demonstrates that MD has considerable negative impact on many aspects of QoL, particularly independence, leisure activities, dealing with personal affairs and mobility. The measure may be valuable for use in clinical trials and routine clinical care.</p>
first_indexed 2024-04-13T11:23:49Z
format Article
id doaj.art-0369ea6a6317472c8d0b18dfe4ebe364
institution Directory Open Access Journal
issn 1477-7525
language English
last_indexed 2024-04-13T11:23:49Z
publishDate 2005-04-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj.art-0369ea6a6317472c8d0b18dfe4ebe3642022-12-22T02:48:44ZengBMCHealth and Quality of Life Outcomes1477-75252005-04-01312510.1186/1477-7525-3-25+Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of lifeffytche TimothyMcMillan Carolyn VAnderson Stephen JWoodcock AlisonWolffsohn James SMitchell JanRubinstein MartinAmoaku WinfriedBradley Clare<p>Abstract</p> <p>Background</p> <p>The MacDQoL is an individualised measure of the impact of macular degeneration (MD) on quality of life (QoL). There is preliminary evidence of its psychometric properties and sensitivity to severity of MD. The aim of this study was to carry out further psychometric evaluation with a larger sample and investigate the measure's sensitivity to MD severity.</p> <p>Methods</p> <p>Patients with MD (n = 156: 99 women, 57 men, mean age 79 ± 13 years), recruited from eye clinics (one NHS, one private) completed the MacDQoL by telephone interview and later underwent a clinic vision assessment including near and distance visual acuity (VA), comfortable near VA, contrast sensitivity, colour recognition, recovery from glare and presence or absence of distortion or scotoma in the central 10° of the visual field.</p> <p>Results</p> <p>The completion rate for the MacDQoL items was 99.8%. Of the 26 items, three were dropped from the measure due to redundancy. A fourth was retained in the questionnaire but excluded when computing the scale score. Principal components analysis and Cronbach's alpha (0.944) supported combining the remaining 22 items in a single scale. Lower MacDQoL scores, indicating more negative impact of MD on QoL, were associated with poorer distance VA (better eye r = -0.431 p < 0.001; worse eye r = -0.350 p < 0.001; binocular vision r = -0.419 p < 0.001) and near VA (better eye r = -0.326 p < 0.001; worse eye r = -0.226 p < 0.001; binocular vision r = -0.326 p < 0.001). Poorer MacDQoL scores were associated with poorer contrast sensitivity (better eye r = 0.392 p < 0.001; binocular vision r = 0.423 p < 0.001), poorer colour recognition (r = 0.417 p < 0.001) and poorer comfortable near VA (r = -0.283, p < 0.001). The MacDQoL differentiated between those with and without binocular scotoma (U = 1244 p < 0.001).</p> <p>Conclusion</p> <p>The MacDQoL 22-item scale has excellent internal consistency reliability and a single-factor structure. The measure is acceptable to respondents and the generic QoL item, MD-specific QoL item and average weighted impact score are related to several measures of vision. The MacDQoL demonstrates that MD has considerable negative impact on many aspects of QoL, particularly independence, leisure activities, dealing with personal affairs and mobility. The measure may be valuable for use in clinical trials and routine clinical care.</p>http://www.hqlo.com/content/3/1/25
spellingShingle ffytche Timothy
McMillan Carolyn V
Anderson Stephen J
Woodcock Alison
Wolffsohn James S
Mitchell Jan
Rubinstein Martin
Amoaku Winfried
Bradley Clare
+Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life
Health and Quality of Life Outcomes
title +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life
title_full +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life
title_fullStr +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life
title_full_unstemmed +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life
title_short +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life
title_sort psychometric evaluation of the macdqol individualised measure of the impact of macular degeneration on quality of life
url http://www.hqlo.com/content/3/1/25
work_keys_str_mv AT ffytchetimothy psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife
AT mcmillancarolynv psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife
AT andersonstephenj psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife
AT woodcockalison psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife
AT wolffsohnjamess psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife
AT mitchelljan psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife
AT rubinsteinmartin psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife
AT amoakuwinfried psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife
AT bradleyclare psychometricevaluationofthemacdqolindividualisedmeasureoftheimpactofmaculardegenerationonqualityoflife